Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum

This session will focus on MedDRA coding of adverse events, with exercises in coding according to ICH conventions. Discussion will be extended to co-medications, safety profile development, and evolution of the safety profile.